| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - paraffin section; human; 1:100; fig 4d
- western blot; human; 1:200; loading ...; fig 3g
| Chu J, Niu X, Chang J, Shao M, Peng L, Xi Y, et al. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma. Theranostics. 2020;10:3488-3502 pubmed publisher |
- western blot; human; loading ...; fig 2b
| Huang X, Gan G, Wang X, Xu T, Xie W. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy. 2019;15:1258-1279 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1b
- immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4g
| Zhang W, Li H, Ogando D, Li S, Feng M, Price F, et al. Glutaminolysis is Essential for Energy Production and Ion Transport in Human Corneal Endothelium. EBioMedicine. 2017;16:292-301 pubmed publisher |
- western blot; human; 1:1000; loading ...; fig 2h
| Villar V, Nguyen T, Delcroix V, Terés S, Bouchecareilh M, Salin B, et al. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun. 2017;8:14124 pubmed publisher |
- western blot; mouse; loading ...; fig 3e
| Davidson S, Papagiannakopoulos T, Olenchock B, Heyman J, Keibler M, Luengo A, et al. Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metab. 2016;23:517-28 pubmed publisher |
| Muthu M, Kumar R, Syed Khaja A, Gilthorpe J, Persson J, Nordstrom A. GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism. Cancers (Basel). 2019;11: pubmed publisher |
| Zhou Q, Zhan H, Lin F, Liu Y, Yang K, Gao Q, et al. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression. Biosci Rep. 2019;39: pubmed publisher |
| Chiche J, Reverso Meinietti J, Mouchotte A, Rubio Patiño C, Mhaidly R, Villa E, et al. GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors. Cell Metab. 2019;29:1243-1257.e10 pubmed publisher |
| Chen Y, Yang Y, Fan X, Lin P, Yang H, Chen X, et al. microRNA-206 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells by targeting glutaminase. Biosci Rep. 2019;: pubmed publisher |
| Bertero T, Oldham W, Grasset E, Bourget I, Boulter E, Pisano S, et al. Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy. Cell Metab. 2019;29:124-140.e10 pubmed publisher |
| Biancur D, Paulo J, Małachowska B, Quiles Del Rey M, Sousa C, Wang X, et al. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun. 2017;8:15965 pubmed publisher |
